FASTING MIMICKING TECHNOLOGY
LIVE

Serial Number

97364195

Owner

L-Nutra Inc.

Attorney

THOMAS J SPEISS III

Filing Date

Apr 14, 2022

Add to watchlist:

No watchlists yet
View on USPTO

FASTING MIMICKING TECHNOLOGY Trademark

Serial Number: 97364195

FASTING MIMICKING TECHNOLOGY is a trademark filed by L-Nutra Inc. on April 14, 2022. The trademark is classified under Class 5 (Pharmaceuticals), Class 42 (Computer & Scientific). The application is currently pending registration.

Owner Contact Info

L-Nutra Inc. (349 trademarks)

Suite 500
Culver City, CA 90232

Entity Type: 03

Trademark Details

Filing Date

April 14, 2022

Registration Date

Not Registered

Published for Opposition

June 6, 2023

Goods & Services

Pharmaceutical preparations, namely, epigenetic drugs for the treatment, diagnosis, detection and prevention of cancer; Pharmaceutical preparations, namely, epigenetic drugs targeting arginine methylation in cancer; pharmaceutical preparations in the nature of inhibitors of arginine methylation for the treatment of cancer; pharmaceutical preparations in the nature of inhibitors of protein arginine methyl-transferase (PRMT) for the treatment of cancer; cancer treatment vaccines; therapeutic vaccines for treating cancer; cancer therapy subsection vaccines; pharmaceutical compounds for the treatment, diagnosis, detection and prevention of cancer; pharmaceutical preparations for the treatment, diagnosis, detection and prevention of cancer; Pharmaceutical preparations, namely, biological preparations and substances for the treatment, diagnosis, detection and prevention of cancer

Research and development services in the pharmaceutical and biotechnology fields; medical research and development services in the pharmaceutical and biotechnology fields; scientific research and development services; pharmaceutical research and development services; research and development in the field of epigenetic drugs for the treatment, diagnosis, detection and prevention of cancer; research and development in the field of epigenetic drugs targeting arginine methylation in cancer; research and development in the field of inhibitors of arginine methylation for the treatment of cancer; research and development in the field of inhibitors of protein arginine methyl-transferase (PRMT) for the treatment of cancer; research and development in the field of cancer treatment vaccines, therapeutic vaccines for treating cancer and cancer therapy subsection vaccines; research and development in the field of compounds for the treatment, diagnosis, detection and prevention of cancer; research and development in the field of pharmaceutical products, preparations and substances for the treatment, diagnosis, detection and prevention of cancer; research and development in the field of biological preparations and substances for the treatment, diagnosis, detection and prevention of cancer; consultancy, advisory and information services relating to and connected with the aforementioned services

Filing History

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Jun 11, 2026 EXRA
SOU EXTENSION 5 GRANTED
Jun 10, 2026 EX5G
CASE ASSIGNED TO INTENT TO USE PARALEGAL
Jun 10, 2026 AITU
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Mar 17, 2026 TCCA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Mar 17, 2026 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Mar 17, 2026 REAP
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Mar 17, 2026 CHAN
TEAS CHANGE OF OWNER ADDRESS RECEIVED
Mar 17, 2026 COAR
SOU TEAS EXTENSION RECEIVED
Jan 16, 2026 EEXT
SOU EXTENSION 5 FILED
Jan 15, 2026 EXT5
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Feb 20, 2025 EXRA
SOU EXTENSION 4 GRANTED
Feb 19, 2025 EX4G
SOU EXTENSION 4 FILED
Feb 19, 2025 EXT4
SOU TEAS EXTENSION RECEIVED
Feb 19, 2025 EEXT
SOU EXTENSION 3 GRANTED
Oct 20, 2024 EX3G
SOU EXTENSION 3 FILED
Oct 20, 2024 EXT3
SOU TEAS EXTENSION RECEIVED
Oct 20, 2024 EEXT
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Sep 12, 2024 TCCA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Sep 12, 2024 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Sep 12, 2024 REAP
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Sep 12, 2024 CHAN
TEAS CHANGE OF OWNER ADDRESS RECEIVED
Sep 12, 2024 COAR
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Jun 13, 2024 EXRA
SOU EXTENSION 2 GRANTED
Jun 11, 2024 EX2G
SOU EXTENSION 2 FILED
Jun 11, 2024 EXT2
SOU TEAS EXTENSION RECEIVED
Jun 11, 2024 EEXT
TEAS CHANGE OF CORRESPONDENCE RECEIVED
May 23, 2024 TCCA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
May 23, 2024 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
May 23, 2024 REAP
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
May 23, 2024 CHAN
TEAS CHANGE OF OWNER ADDRESS RECEIVED
May 23, 2024 COAR
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Jan 26, 2024 EXRA
SOU EXTENSION 1 GRANTED
Jan 24, 2024 EX1G
SOU EXTENSION 1 FILED
Jan 24, 2024 EXT1
SOU TEAS EXTENSION RECEIVED
Jan 24, 2024 EEXT
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Aug 1, 2023 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Jun 6, 2023 NPUB
PUBLISHED FOR OPPOSITION
Jun 6, 2023 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
May 17, 2023 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
May 2, 2023 CNSA
EXAMINER'S AMENDMENT ENTERED
May 1, 2023 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
May 1, 2023 GNEN
EXAMINERS AMENDMENT E-MAILED
May 1, 2023 GNEA
EXAMINERS AMENDMENT -WRITTEN
May 1, 2023 CNEA
TEAS/EMAIL CORRESPONDENCE ENTERED
Apr 8, 2023 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Apr 7, 2023 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Apr 7, 2023 TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Apr 7, 2023 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Oct 7, 2022 GNRN
NON-FINAL ACTION E-MAILED
Oct 7, 2022 GNRT
NON-FINAL ACTION WRITTEN
Oct 7, 2022 CNRT
ASSIGNED TO EXAMINER
Sep 26, 2022 DOCK
ASSIGNED TO EXAMINER
Sep 21, 2022 DOCK
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Jun 8, 2022 TCCA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Jun 8, 2022 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Jun 8, 2022 REAP
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Apr 20, 2022 NWOS
NEW APPLICATION ENTERED
Apr 18, 2022 NWAP